Pharma Technology
Pharma Technology, headquartered in Belgium, is a leading player in the pharmaceutical technology sector, specialising in innovative solutions for drug development and manufacturing. Founded in 2001, the company has established a strong presence across Europe and beyond, focusing on areas such as process optimisation, quality assurance, and regulatory compliance. With a commitment to excellence, Pharma Technology offers a range of core services, including consultancy, training, and software solutions tailored to the unique needs of the pharmaceutical industry. Their expertise in integrating cutting-edge technology with industry best practices sets them apart in a competitive market. Recognised for their contributions to enhancing operational efficiency, Pharma Technology has achieved significant milestones, solidifying its position as a trusted partner for pharmaceutical companies seeking to navigate complex regulatory landscapes and improve product quality.
DitchCarbon Score
How does Pharma Technology's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharma Technology's score of 6 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharma Technology's reported carbon emissions
Pharma Technology, headquartered in Belgium, currently does not have available carbon emissions data for the most recent year. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not provided. In the absence of concrete emissions data, it is important to note that Pharma Technology has not outlined any specific reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. This lack of publicly available information suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Pharma Technology to establish clear climate commitments and reduction initiatives to align with global efforts to mitigate climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharma Technology is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
